In Germany, an estimated 7.3 million women experience menopause-related symptoms that warrant medical attention. These symptoms can significantly impact both health and workplace performance, highlighting the urgent need for targeted healthcare interventions during this stage of life.

On average, it takes three years for women experiencing menopause-related symptoms to receive appropriate medical care. The platform addresses this delay by encouraging employers to offer menopause care as part of their health benefits package, thereby raising awareness among employees. This can foster a broader understanding of menopause among both male and female employees, promoting timely recognition and care. Through comprehensive health data tracking, AI-driven personalized anamnesis, and individualized patient education, the platform supports earlier diagnosis and intervention, helping to reduce the healthcare gap in menopause care.

In a self-reported survey, 92% of platform users noted significant improvements in their health and well-being after utilizing the services. These outcomes suggest the platform’s efficacy in addressing menopause-related health challenges, particularly in terms of symptom management and care accessibility.

The platform provides users with access to a broad catalogue of menopause specialists, who can be booked directly through the platform. This ensures that women have a wide variety of treatment options and can even seek second opinions, promoting more personalized and well-rounded care. The platform is designed to be user-friendly, ensuring that women of all technological skill levels can easily navigate it.

The platform offers flexible payment models, including employer-sponsored care options, making it accessible to a wide range of users. The educational courses provided are priced competitively, offering substantial value compared to market standards, while care and coaching services remain consistent with industry norms.

At present, the efficacy data is based on self-reported outcomes, with 92% of users expressing improvement in symptoms. Continued data collection and validation efforts are underway to strengthen the evidence base supporting the platform's effectiveness.